As mentioned above, interference with the KIT-mediated and FcεRI-mediated signal pathways has been proposed as a potential strategy to control mast cell-mediated allergic reactions [13,14], highlighting the importance of KIR2DL4 as a target for allergic diseases. Here, KIT is linked to allergic disease.